Bepreve  (U.S.N.L.M.)
Dosing 1 drop bid
Chem Specs bepotastine besilate 1.5%
Quantities 10ml
Cost 246.00/10ml
Class H1 receptor antagonist
Action Competitive H1 receptor inhibitor.  Mast cell stabilizer.
Usage Indicated for the treatment of itching associated with allergic conjunctivitis.
Contact lenses may be inserted 10 minutes after administration.
Contraindications Hypersensitivity to any component of the product..
Pediatric use Safety and efficacy not established for patients under 2 years of age.
Pregnancy Skeletal anomalies produced in rats at 5400x human dosage but not at 3300x.
Rat maternal lethality observed at 540x the normal human ophthalmic dose.
BAK .005%
    N.L.M. DailyMed page for Bepreve          PDR page for Bepreve